Efficacy and Safety of Ultra-Rapid Lispro Versus Lispro in Patients with Type 1 and 2 Diabetes: Indian Subpopulation Analyses of the PRONTO-T1D and PRONTO-T2D Trials

Detalles Bibliográficos
Autores principales: Bhattacharyya, Arpandev, Bhattacharya, Indranil, Deshmukh, Vaishali, Mohan, Viswanathan, Spaepen, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302417/
https://www.ncbi.nlm.nih.gov/pubmed/35873944
http://dx.doi.org/10.4103/ijem.ijem_459_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302417/
https://www.ncbi.nlm.nih.gov/pubmed/35873944
http://dx.doi.org/10.4103/ijem.ijem_459_21

Ejemplares similares